Nexien Biopharma, Inc., formerly Intiva BioPharma, Inc., is a drug development company. The Company is engaged in the business of developing drugs containing cannabinoids or terpenes, for the treatment of various diseases, disorders and medical conditions.

Information Technology

Nexien Biopharma

Richard S. Greenberg

sam kim

Tae Joon Song

Young Kwon

Wilson Han

Kwangjin (KJ) Suk

Junho Kim

Jessica Kim

Jangwon Suh

Robert I. Goldfarb

Evan Wasoff

The executive team at Nexien Biopharma has experience in the pharmaceutical and legal industries. The team members have degrees in law and economics from Rutgers University School of Law and City University of New York-Queens College, respectively.

CEO and Executive Team

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Nexien Biopharma

Leadership Team